Envudeucitinib Investor Call - AAD 2026 Phase 3 ONWARD Data March 29, 2026 7:00 PM EDT Click here for webcast Supporting Materials Envudeucitinib ONWARD1 and ONWARD2 Phase 3 Data Presentation 2.7 MB
